Glucocorticoid receptors in major depression: Relevance to pathophysiology and treatment

Biological Psychiatry

Volumn 49, Issue 5, 2001, Pages 391-404

  Pariante, Carmine M ^a   Miller, Andrew H ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adrenocorticotropin hormone; Antidepressants; Corticotropin releasing hormone; Cortisol; Hypothalamic pituitary adrenal axis; Neuroendocrinology

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; DESIPRAMINE; DEXAMETHASONE; FLUOXETINE; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; IDAZOXAN; IMIPRAMINE; LITHIUM; MIANSERIN; MIRTAZAPINE; MOCLOBEMIDE; OXAPROTILINE; PHENELZINE; TRAZODONE; ZIMELDINE;

CHEMOSENSITIVITY; CLINICAL TRIAL; DEPRESSION; DEXAMETHASONE SUPPRESSION TEST; DRUG EFFECT; DRUG RECEPTOR BINDING; ELECTRIC SHOCK; HORMONE RECEPTOR INTERACTION; HUMAN; HYPERACTIVITY; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR AFFINITY; RECEPTOR DOWN REGULATION; REVIEW; SECOND MESSENGER;

ANTI-INFLAMMATORY AGENTS; ANTIDEPRESSIVE AGENTS; CORTICOTROPIN-RELEASING HORMONE; DEPRESSIVE DISORDER, MAJOR; DEXAMETHASONE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; PITUITARY-ADRENAL SYSTEM; RECEPTORS, GLUCOCORTICOID;

EID: 0035280252     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(00)01088-X     Document Type: Review

References (98)

1. The relationship of the dexamethasone suppression test (1 mg and 2 mg) to basal plasma cortisol levels in endogenous depression
2. Reduced G protein functions and immunoreactive levels in mononuclear leukocytes of patients with depression
3. Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids
4. Indole-pyruvic acid, a tryptophan ketoanalogue, antagonizes the endocrine but not the behavioral effects of repeated stress in a model of depression
5. The antidepressants fluoxetine, idazoxan and phenelzine alter corticotropin-releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: Therapeutic implications
6. Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain
7. Antidepressant drugs inhibit glucocorticoid receptor mediated gene transcription - A possible mechanism
8. The effect of chronic treatment with antidepressant drugs on the corticosteroid receptor levels in the rat hippocampus
9. Cortisol suppression per nanogram per milliliter of plasma dexamethasone in depressive and normal subjects
10. Chronic antidepressant treatment facilitates G protein activation of adenylyl cyclase without altering G protein content
11. Chronic treatment of C6 glioma cells with antidepressant drugs increases functional coupling between a G protein (Gs) and adenylyl cyclase
12. Brain corticosteroid receptor balance in health and disease
13. The novel antidepressant, tianeptine, reduces stress-evoked stimulation of the hypothalamo-pituitary-adrenal axis
14. Differential autoregulation of glucocorticoid receptor expression in human T- and B-cell lines
15. Pulse-dosing and conventional application of doxepin: Effects on psychopathology and hypothalamus-pituitary-adrenal axis
16. Differential effects of chronic antidepressant treatment on swim stress and fluoxetine induced secretion of corticosterone and progesterone
17. Ligand-independent activation of the glucocorticoid receptor by Beta2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells
18. Increased synaptic availability of norepinephrine following desipramine is not essential for increases in GR mRNA
19. Clinical and biochemical manifestation of depression. Relation to the neurobiology of stress
20. Glucocorticoid receptors in depression: Relationship to the dexamethasone suppression test
21. Intracellular traffic of steroid hormone receptors
22. The combined dexamethasone/CRH test: A refined laboratory test for psychiatric disorders
23. Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects
24. Antidepressants and hypothalamic-pituitary-adrenocortical regulation
25. Lymphocyte glucocorticoid receptor binding in depression: Normal values following recovery
26. Sickness behavior as a new target for drug development
27. Effects of chronic imipramine treatment on glucocorticoid receptor immunoreactivity in various regions of the rat brain
28. Lack of association between five polymorphisms in the human glucocorticoid receptor gene and glucocorticoid resistance
29. Mitogen-activated and cyclin-dependent protein kinases selectively and differentially modulate transcriptional enhancement by the glucocorticoid receptor
30. Reversal of neonatal maternal separation phenotype by reboxetine
31. The glucocorticoid insensitivity syndrome
32. 24-Hour profiles of adrenocorticotropin, cortisol, and growth hormone in major depressive illness: Effect of antidepressant treatment
33. Regulation of serotonin 1A, glucocorticoid and mineralocorticoid receptor in rat and human hippocampus: Implications for the neurobiology of depression
34. Reserpine-induced decrease in Type I and II corticosteroid receptors in neuronal and lymphoid tissues of adrenalectomized rats
35. Glucocorticoid resistance in depression: The dexamethasone suppression test and lymphocyte sensitivity to dexamethasone
36. Comparison of in vivo and in vitro glucocorticoid sensitivity in depression: Relationship to the dexamethasone suppression test
37. Relationship between interleukin-6 activity, acute phase proteins, and the function of the hypothalamic-pituitary-adrenal axis in severe depression
38. Plasma sialyltransferase levels in psychiatric disorders as a possible indicator of HPA function
39. The role of IL-6 type cytokines and their receptors in bone
40. Bone mineral density in women with depression
41. The in vitro effect of cortisol on natural killer cell activity in patients with major depressive disorder
42. Effects of cytokines on glucocorticoid receptor expression and function: Glucocorticoid resistance and relevance to depression
43. Lack of association between cortisol hypersecretion and nonsuppression on the DST in patients with Alzheimer's disease
44. Glucocorticoid receptors are differentially expressed in the cells and tissues of the immune system
45. Adrenal steroid receptor activation in rat brain and pituitary following dexamethasone: Implications for the dexamethasone suppression test
46. Hormonal response pattern in the combined DEX-CRH test is stable over time in subjects at high familiar risk for affective disorder
47. Long-term antidepressant treatment reduces behavioural deficits in transgenic mice with impaired glucocorticoid receptor function
48. The corticotropin-releasing factor (CRF) hypothesis of depression: New findings and new directions
49. Chronic antidepressant administration alters the subcellular distribution of cyclic AMP-dependent protein kinase in rat frontal cortex
50. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus
51. Glucocorticoids and interferon-alpha in the acquired immunodeficiency syndrome
52. Long-term treatment with antidepressants increases glucocorticoid receptor binding and gene expression in cultured rat hippocampal neurones
53. An alternative ligand-independent pathway for activation of steroid receptors
54. The role of CRF in the pathophysiology of affective disorders: Laboratory and clinical studies
55. Steroid-independent translocation of the glucocorticoid receptor by the antidepressant desipramine
56. The proinflammatory cytokine, interleukin-1 alpha, reduces glucocorticoid receptor translocation and function
57. Effects of chronic antidepressant treatment on the hypothalamic-pituitary-adrenal axis of Wistar rats
58. Antidepressant and other centrally acting drugs regulate glucocorticoid receptor messenger RNA levels in rat brain
59. Differential regulation by dexamethasone of glucocorticoid receptor messenger RNA concentrations in neuronal cultures derived from fetal rat hypothalamus and cerebral cortex
60. Increased glucocorticoid receptor gene promoter activity after antidepressant treatment
61. Antidepressant drug action in a transgenic mouse model of the endocrine changes seen in depression
62. The role of heat shock proteins in regulating the function, folding, and trafficking of the glucocorticoid receptor
63. The effect of long-term treatment with antidepressant drugs on the hippocampal mineralocorticoid and glucocorticoid receptors in rats
64. The effect of repeated combined treatment with nifedipine and antidepressant drugs or electroconvulsive shock on the hippocampal corticosteroid receptors in rats
65. Modulation of glucocorticoid receptor function by protein kinase A
66. Two receptor systems for corticosterone in rat brain: Microdistribution and differential occupation
67. Hypothalamic-pituitary-adrenocortical axis changes in the rat after long-term treatment with the reversible monoamine oxidase-A inhibitor moclobemide
68. Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system
69. Norepinephrine-independent regulation of GRII mRNA in vivo by a tricyclic antidepressant
70. Disturbed glucocorticoid receptor autoregulation and corticotropin response to dexamethasone in depressives pretreated with metyrapone
71. Lymphocyte glucocorticoid receptor binding during depression and after clinical recovery
72. In vivo and in vitro effects of glucocorticoids on lymphocyte proliferation in depression
73. Protein kinase cascades in intracellular signaling by interleukin-I and tumor necrosis factor
74. Lymphocyte glucocorticoid receptor: Predictor of sertraline response in adolescent major depressive disorder (MDD)
75. Heat shock induces translocation of the unliganded glucocorticoid receptor
76. Potentiation of glucocorticoid receptor-mediated gene expression by heat and chemical shock
77. Structural and functional reconstitution of the glucocorticoid receptor-hsp90 complex
78. Lymphocyte glucocorticoid receptor binding in depressed patients with hypercortisolemia
79. Low lumbar bone mineral density in patients with major depression
80. Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNA expression in rat hippocampus in vivo
81. cAMP-dependent protein kinase activity in major depression
82. Steroid-resistant asthma: Cellular mechanisms contributing to inadequate response to glucocorticoid therapy
83. Glucocorticoid receptor in peripheral mononuclear leukocytes from patients with ulcerative colitis
84. Evidence for mineralocorticoid receptor facilitation of glucocorticoid receptor-dependent regulation of hypothalamic-pituitary-adrenal axis activity
85. Corticosterone regulation of type I and type II adrenal steroid receptors in brain, pituitary, and immune tissue
86. A whole-cell assay for glucocorticoid binding sites in normal human lymphocytes
87. Increased intra-abdominal fat deposition in patients with major depression illness as measured by computed tomography
88. Regulation of glucocorticoid receptor-mRNA in human blood cells by amitriptyline and dexamethasone
89. Glucocorticoid receptor binding in three different cell types in major depressive disorder: Lack of evidence of receptor binding defect
90. Mononuclear leukocyte glucocorticoid receptor binding characteristics and down-regulation in major depression
91. Decreased glucocorticoid receptor mRNA levels in individuals with depression, bipolar disorder and schizophrenia
92. Glucocorticoid receptors and depression
93. Normal lymphocyte responsiveness to lectins but impaired sensitivity to in vitro glucocorticoids in major depression
94. Cell-mediated immunity and its glucocorticoid-sensitivity after clinical recovery from severe major depressive disorder
95. Glucocorticoids, hippocampal corticosteroid receptor gene expression and antidepressant treatment: Relationship with spatial learning in young and aged rats
96. Glucocorticoid receptor number and cortisol excretion in mood, anxiety and psychotic disorders
97. Loss of glucocorticoid fast feedback in depression
98. Changes at multiple levels of the hypothalamo-pituitary adrenal axis following repeated electrically induced seizures